University Growth Fund

Merrimack Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, design, and development of therapies for the treatment of diseases in the areas of autoimmunity and cancer. It develops MM-093, a human alpha-fetoprotein for the treatment of patients with rheumatoid arthritis and psoriasis; and MM-121, a human monoclonal antibody and therapeutic to block signaling of the ErbB3 receptor. Merrimack Pharmaceuticals, Inc. was formerly known as Atlantic BioPharmaceuticals, Inc. The company was founded in 1993 and is based in Cambridge, Massachusetts.

TrustedID, Inc. provides proactive identity protection solutions for corporations, organizations, and government agencies. It offers IDEssentials, a protection system that enables users to detect and stop identity theft before it happens. The company also provides data breach response services that offer identity protection for the victims of various data breach. It offers its products through financial institutions and consumer brands, as well as directly through www.trustedid.com. TrustedID acquired Unsubscribe.com and Reppler.com in 2011. The company was founded in 2005 and is based in Palo Alto, California.

Catheter Connections, Inc. develops and commercializes vascular access products to protect patients from acquiring infections during intravenous infusion therapy (IV). The company offers DualCap System, a set of user-friendly products that provides healthcare facilities with an integrated solution for IV disinfection and protection by helping in the fight against IV catheter-related blood stream infections. Its DualCap System safely disinfects IV tubing end connectors and IV catheter access valves for infection control. The company offers its products through sales representatives. Catheter Connections, Inc. was founded in 2008 and is based in Salt Lake City, Utah. As of January 31, 2017, Catheter Connections, Inc. operates as a subsidiary of Merit Medical Systems, Inc.

Beereaders is a digital platform that promotes literacy skills among Spanish-speaking students presenting personalized learning and using original Spanish content in a game-like experience.

Recyclops is a startup technology company that innovates customer-centric and sustainability solutions. Recyclops leverages technology and local communities to bring recycling to communities that normally wouldn’t have access to it. It was founded in 2013 and headquartered in Orem, Utah.

The Transpond Apps Platform enables brands to easily create, publish, manage and track engagement with their content across social and mobile platforms. Fully branded apps created with the Transpond platform deliver consumer engagement around polls, quizzes, games, interactive commerce and content syndication, and can be instantly distributed across the social, web and mobile platforms. Designed for ease-of-use by marketing professionals, Transpond helps make all content engaging, social and measurable across all consumers touch points without the need for costly custom engineering. Customers include CBS, Revision3, TV.com, Lifetime Television, Universal Music Group, NBC Universal, Scion, Visa and others.

Vutiliti gathers and provides real-time information on utility usage so that consumers, businesses, and governments can monitor and budget utility usage. Its mobile and web programs guide consumers to actual consumption reduction, saving them money while reducing the usage of water, gas, and electricity generation. Vutiliti was established in 2015 and is headquartered in Sandy, Utah.

Beereaders is a digital platform that promotes literacy skills among Spanish-speaking students presenting personalized learning and using original Spanish content in a game-like experience.

Ancora Pharmaceuticals, Inc., a biopharmaceutical company, develops immune system modulation therapeutics using synthetic carbohydrates in the United States. Its products include vaccines against bacterial, parasitic, and viral infectious diseases, as well as therapeutics to treat cardiovascular and metabolic diseases. The company was incorporated in 2001 and is based in Medford, Massachusetts. As of October 31, 2013, Ancora Pharmaceuticals, Inc. operates as a subsidiary of Corden Pharma Switzerland LLC.

Alianza radically transforms communications delivery so that service providers thrive with strong margins, better service, and elegant management. Alianza’s Cloud Voice Platform is a web-scale, turnkey virtualized software solution that enables cable, mobile, telco and other broadband providers to rapidly customize, launch and profit from VoIP and UC services. The power of Alianza’s cloud delivers a lower total cost of ownership and a clear business case for VoIP with a zero-CAPEX, success-based SaaS model. This new way to deliver voice service untangles service providers from the restraints of old-school voice networks and accelerates innovation and growth. Customers include Blue Ridge Communications, WEHCO Media, ViaSat, Vyve Broadband and Xplornet.

Each year approximately 3,000 people in the US die because of incorrectly placed feeding tubes. Veritract is developing feeding tubes with integrated optics and steering allowing precision tube placement and confirmation in the GI tract through direct vision. Their technology can be utilized to prevent unnecessary deaths or serious complications.

BaroSense is committed to develop and commercialize novel anti-obesity products that provide a meaningful contribution to this leading healthcare problem facing the United States today. BaroSense was conceived in order to create a safe, simple, effective, and minimally invasive alternative to the surgical treatment of obesity - an innovative approach to assist those people who need help beyond traditional diets, and who wish to avoid extensive, irreversible surgery.

Daz Productions, Inc., doing business as Daz 3D, develops 3D models and 3D software solutions. The company provides 3D models and content for movies, video games, and comic books. It also sells its products online. The company was founded in 2000 and is based in Salt Lake City, Utah.

Coherex Medical, Inc. develops medical devices for addressing the structural heart disease conditions. It offers patent foramen ovale (PFO) closure system, which is designed to stimulate tissue in-growth to ensure long-term closure of the PFO. The company was founded as Proximare, Inc. in 2003 and changed its name to Coherex Medical, Inc. in 2006. The company is based in Salt Lake City, Utah.

Workfront is a cloud-based Enterprise Work Management solution that helps marketing teams, creative agencies, and other enterprise teams conquer the chaos of excessive email, redundant status meetings, and disconnected tools. Unlike other tools, Workfront Enterprise Work Cloud is a centralized, easy-to-adopt solution for managing and collaborating on all types of work through the entire work lifecycle, which improves team productivity and executive visibility. Workfront is trusted by thousands of global enterprises, like Cars.com, Cisco Systems, Comcast, iProspect, Schneider Electric, and Trek. To learn more, visit www.workfront.com or follow us on Twitter @Workfront_Inc.

Salus Therapeutics Inc., a privately held biotechnology company founded in July 1999 and located in Salt Lake City, uses a proprietary "OptiSense(R)" technology for the discovery of new oligonucleotide-based medicines. The company's unique co-polymers are used as transfection vehicles to deliver RNA- and DNA-based drugs.

Galvanize is a school for entrepreneurs, engineers, and data scientists. It is a learning community for technology with nine physical and two remote campuses, where innovative startups, aspiring students, and large enterprises benefit from this dynamic, unique business ecosystem. Galvanize is backed by investors including, but not limited to, Catalyst Investors, ABS Capital Partners, University Ventures, New Markets Venture Partners, and Colorado Impact Fund. The company was co-founded by Tony Mugavero, Chris Onan, Jim Deters, and Lawrence Mandes in 2012, and is headquartered in Denver, Colorado.

Personalized automation and control solutions that allow virtual control of any device in homes and businesses

Company that produces enterprise social software via its integrated suite of web-based social apps

Advent Solar produces silicon photovoltaic cell-to-module technology. Based in Albuquerque, New Mexico, U.S.A., the company focuses on delivering intellectual property (IP) for intelligent, high-energy silicon photovoltaic (PV) solutions. With patented, advanced technologies, Advent Solar enables higher value products that are Beautiful by Design™, changing the rules for smart grid economics. Advent Solar provides its industry-leading Ventura™ Technology through a licensing model. Ventura Solar Technology is a comprehensive cell-to-module architecture for high-performance solar modules that deliver the industry’s best value for silicon PV modules.

BaroSense is committed to develop and commercialize novel anti-obesity products that provide a meaningful contribution to this leading healthcare problem facing the United States today. BaroSense was conceived in order to create a safe, simple, effective, and minimally invasive alternative to the surgical treatment of obesity - an innovative approach to assist those people who need help beyond traditional diets, and who wish to avoid extensive, irreversible surgery.

Lineagen, Inc. operates as a genetics diagnostic company that focuses on genetic testing and clinical information services for various neurodevelopmental disorders. It offers FirstStepDx PLUS, a chromosomal microarray platform that is optimized to detect genomic changes associated with autism and neurodevelopmental disorders; NextStepDx PLUS, a genetic sequencing test to detect small changes in the genome; and M-CHAT.org, an online screening tool for physicians and parents to assess developmental evaluation, such as ADI/ADOS. It serves healthcare professionals, physicians, and individuals. Lineagen, Inc. was formerly known as GenData Research Corporation and changed its name to Lineagen, Inc. in January 2003. The company was founded in 2002 and is based in Salt Lake City, Utah. As of August 21, 2020, Lineagen, Inc. operates as a subsidiary of Bionano Genomics, Inc.

Lineagen, Inc. operates as a genetics diagnostic company that focuses on genetic testing and clinical information services for various neurodevelopmental disorders. It offers FirstStepDx PLUS, a chromosomal microarray platform that is optimized to detect genomic changes associated with autism and neurodevelopmental disorders; NextStepDx PLUS, a genetic sequencing test to detect small changes in the genome; and M-CHAT.org, an online screening tool for physicians and parents to assess developmental evaluation, such as ADI/ADOS. It serves healthcare professionals, physicians, and individuals. Lineagen, Inc. was formerly known as GenData Research Corporation and changed its name to Lineagen, Inc. in January 2003. The company was founded in 2002 and is based in Salt Lake City, Utah. As of August 21, 2020, Lineagen, Inc. operates as a subsidiary of Bionano Genomics, Inc.